Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00501579 · ClinicalTrials.gov registry record · Phase 3
Study of Difluprednate in the Treatment of Uveitis
A Phase 3 study of Uveitis, sponsored by Sirion Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Study location
NCT00501579: Completed Phase 3 study of Uveitis, sponsored by Sirion Therapeutics.
NCT00501579 is a Phase 3 study of Uveitis that has completed, run by Sirion Therapeutics. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00501579, a Phase 3 study of Uveitis, has completed, sponsored by Sirion Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.
Conditions Studied
Interventions
- DRUG Difluprednate
- DRUG Prednisolone Acetate
Study Locations (1)
Indiana
- John-Kenyon American Eye Institute - New Albany
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 3 |
What the finished NCT00501579 record still lists
NCT00501579 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Uveitis appearing as the primary indexed condition, and to 2 interventions - of which Difluprednate is the first listed.
NCT00501579 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT00501579 about?
NCT00501579 is a clinical study titled "Study of Difluprednate in the Treatment of Uveitis". The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.
What is the current status of trial NCT00501579?
This trial is currently completed. It is a Phase 3 study.
What conditions does trial NCT00501579 study?
This clinical trial studies the following conditions: Uveitis.
What interventions are being tested in trial NCT00501579?
The interventions under investigation include: Difluprednate (DRUG), Prednisolone Acetate (DRUG).
Who is sponsoring clinical trial NCT00501579?
This trial is sponsored by Sirion Therapeutics, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00501579 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uveitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
RECRUITING · Phase 3
-
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
ACTIVE NOT RECRUITING · Phase 3
-
Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
COMPLETED · Phase 3
-
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
COMPLETED · Phase 3
-
Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial
COMPLETED · Phase 3
-
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
RECRUITING